Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Coppo

Showing results (21-30 of 199) with videos related to

Pageof 20
Sort By:
Research and Practice in Thrombosis and Haemostasis|January 19, 2019
Thrombotic thrombocytopenic purpura: Toward targeted therapy and precision medicinePaul Coppo, Adam Cuker, James N George
La Revue Du Praticien|March 22, 2013
[Thrombotic microangiopathies]Constance Moulinier, Agnès Veyradier, Eric Rondeau, et al.
Presse Medicale (Paris, France : 1983)|July 14, 2012
[Polyclonal CD8+/CD57+ T cell expansions: clinical significance]Paul Coppo, Marc Buffet, Frédéric Féger, et al.
Clinical Case Reports|December 17, 2016
Mature CD8<sup>+</sup> T-cell clonal expansion in the oral cavity and digestive tract: a severe lymphoid malignancy that mimics Crohn's diseasePaul Coppo, Bettina Fabiani, Christophe Marzac, et al.
Expert Opinion on Biological Therapy|July 31, 2019
Caplacizumab: a change in the paradigm of thrombotic thrombocytopenic purpura treatmentMaëlle le Besnerais, Agnès Veyradier, Ygal Benhamou, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 31, 2026
Treating Immune-Mediated Thrombotic Thrombocytopenic Purpura with CaplacizumabJúlia Weisinger, Bérangère S Joly, Agnès Veyradier, et al.
Stroke|March 7, 2025
Thrombotic Thrombocytopenic Purpura: A Missed Cause in Stroke Prevention GuidelinesAdrien Picod, Bérangère S Joly, Agnès Veyradier, et al.
Blood|July 3, 2024
Thrombotic thrombocytopenic purpura: 100 years of research on Moschcowitz syndromeSpero R Cataland, Paul Coppo, Marie Scully, et al.
Cellular Signalling|October 7, 2008
BCR-ABL induces opposite phenotypes in murine ES cells according to STAT3 activation levelsPaul Coppo, Isabelle Dusanter-Fourt, William Vainchenker, et al.
Clinical Case Reports|December 30, 2022
Cytomegalovirus lymphadenitis mimicking a relapsed diffuse large B-cell lymphomaMatthieu Delaye, Laure Ricard, Lucas Maisonobe, et al.
Pageof 20

Showing results (21-30 of 199) with videos related to

Sort By:
Pageof 20
Research and Practice in Thrombosis and Haemostasis|January 19, 2019
Thrombotic thrombocytopenic purpura: Toward targeted therapy and precision medicinePaul Coppo, Adam Cuker, James N George
La Revue Du Praticien|March 22, 2013
[Thrombotic microangiopathies]Constance Moulinier, Agnès Veyradier, Eric Rondeau, et al.
Presse Medicale (Paris, France : 1983)|July 14, 2012
[Polyclonal CD8+/CD57+ T cell expansions: clinical significance]Paul Coppo, Marc Buffet, Frédéric Féger, et al.
Clinical Case Reports|December 17, 2016
Mature CD8<sup>+</sup> T-cell clonal expansion in the oral cavity and digestive tract: a severe lymphoid malignancy that mimics Crohn's diseasePaul Coppo, Bettina Fabiani, Christophe Marzac, et al.
Expert Opinion on Biological Therapy|July 31, 2019
Caplacizumab: a change in the paradigm of thrombotic thrombocytopenic purpura treatmentMaëlle le Besnerais, Agnès Veyradier, Ygal Benhamou, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 31, 2026
Treating Immune-Mediated Thrombotic Thrombocytopenic Purpura with CaplacizumabJúlia Weisinger, Bérangère S Joly, Agnès Veyradier, et al.
Stroke|March 7, 2025
Thrombotic Thrombocytopenic Purpura: A Missed Cause in Stroke Prevention GuidelinesAdrien Picod, Bérangère S Joly, Agnès Veyradier, et al.
Blood|July 3, 2024
Thrombotic thrombocytopenic purpura: 100 years of research on Moschcowitz syndromeSpero R Cataland, Paul Coppo, Marie Scully, et al.
Cellular Signalling|October 7, 2008
BCR-ABL induces opposite phenotypes in murine ES cells according to STAT3 activation levelsPaul Coppo, Isabelle Dusanter-Fourt, William Vainchenker, et al.
Clinical Case Reports|December 30, 2022
Cytomegalovirus lymphadenitis mimicking a relapsed diffuse large B-cell lymphomaMatthieu Delaye, Laure Ricard, Lucas Maisonobe, et al.
Pageof 20